NAB2 and neoplasm: Hayenga and colleagues demonstrated that ASOs can efficiently downregulate the expression of NAB2-STAT6 fusion transcripts in vitro and in vivo, and, importantly, exert anti-tumor effects in vivo using SFT cell line models and PDX mouse models.